Grants per year
Fingerprint
Dive into the research topics where Daniel Egan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Active
-
-
Biology of Non-Response to Induction Therapy in Adult AML
Egan, D. (PI)
American Society of Clinical Oncology
01/1/15 → …
Project: Research
-
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/ refractory acute myeloid leukemia and B-cell malignancies
Davids, M. S., Brander, D. M., Alvarado-Valero, Y., Diefenbach, C. S., Egan, D. N., Dinner, S. N., Javidi-Sharifi, N., Al Malki, M. M., Begna, K. H., Bhatt, V. R., Abedin, S., Cook, R. J., Collins, M. C., Roleder, C., Dominguez, E. C., Rajagopalan, P., Wiley, S. E., Ghalie, R. G. & Danilov, A. V., Feb 25 2025, In: Blood Advances. 9, 4, p. 820-832 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
Mazziotta, F., Martin, L. E., Egan, D. N., Bar, M., Kinsella, S., Paulson, K. G., Voillet, V., Lahman, M. C., Hunter, D., Schmitt, T. M., Duerkopp, N., Yeung, C. C. S., Tang, T. H., Gottardo, R., Asano, Y., Wilcox, E. C., Lee, B., Zhang, T., Lopedote, P. & Penter, L. & 4 others, , Dec 2025, In: Nature Communications. 16, 1, 5214.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
268 - Outpatient CAR T Cell Therapy Is Safe and Feasible in Patients with Lymphoma Treated in Non-University Medical Centers: A Multicenter, Retrospective Analysis
Patel, K., Bailey, M., Bailey, N., Fanning, S., Gulley, K., Frisvold, J., Glennie, S., Dunleavy, V., Benitez-Kruidenier, S., Parker, J., Williams, S., Sullivan, S., Dean, C., Hohmann, H., Lu, C., Tierney, C., Mun, G., Egan, D. N. & Essell, J., Feb 1 2023Research output: Other contribution
-
307 - A Prospective Randomized Trial Comparing Conditioning with Either BEAM or High-Dose Melphalan Prior to Autologous Transplantation for Patients with Multiple Myeloma: An Evaluation of Interim Safety in Early Recovery Phase
Bailey, M., Tsomo, T., Bailey, N., Braun, T., Lu, C., Dean, C., Williams, S., Funk, G., Fesler, J., Glennie, S., Hall, J., Dunleavy, V., Egan, D. N., Mawad, R., Hegerova, L., Patel, K., Pagel, J. M. & Bensinger, W., Mar 18 2022Research output: Other contribution
-
Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Bailey, N., Braun, T., Bailey, M., Tsomo, T., Szeto, J., Kruidenier, S. B., Dunleavy, V., Fesler, J., Funk, G., Glennie, S., Hall, J., Parker, J., Egan, D. N., Mawad, R., Dean, C. A., Sullivan, S., Lu, C., Hohmann, H., Briggs, J. & Patel, K., Nov 15 2022Research output: Other contribution